CIMATRON LIMITED
CONSOLIDATED STATEMENTS OF INCOME
(US Dollars in thousands, except for per share data)
Three months ended
March 31,
2009 2008
Total revenue 7,843 10,006
Total cost of revenue 1,508 1,994
Gross profit 6,335 8,012
Research and development expenses, net 1,415 1,757
Selling, general and administrative expenses 5,432 6,473
Operating loss (512) (218)
Financial income (expenses), net. (141) (45)
Taxes on Income 81 (41)
Other 9 6
Net loss $ (563) $ (298)
Net loss per share - basic and diluted $ (0.06) $ (0.03)
Weighted average number of shares outstanding
Basic EPS (in thousands) 9,224 9,357
Diluted EPS (in thousands) 9,224 9,462
CIMATRON LIMITED
RECONCILIATION BETWEEN GAAP AND NON-GAAP INFORMATION
(US Dollars in thousands, except for per share data)
Three months ended March 31,
2009 2008
GAAP Adj. NON-GAAP GAAP Adj. NON-GAAP
Total revenue (1) 7,843 7,843 10,006 248 10,254
Total cost of
revenue (2) 1,508 (147) 1,361 1,994 (147) 1,847
Gross profit 6,335 147 6,482 8,012 395 8,407
Research and
development
expenses, net 1,415 1,415 1,757 - 1,757
Selling, general
and administrative
expenses (2) 5,432 (100) 5,332 6,473 (100) 6,373
Operating income
(loss) (512) 247 (265) (218) 495 277
Financial income
(expenses), net. (141) - (141) (45) - (45)
Taxes on Income (3) 81 (91) (10) (41) 38 (3)
Other 9 - 9 6 - 6
Net income (loss) $(563) $156 $(407) $(298) $533 $235
Net income (loss)
per share - basic
and diluted $(0.06) $(0.04) $(0.03) $0.02
Weighted average
number of shares
outstanding
Basic EPS (in
thousands) 9,224 9,224 9,357 9,357
Diluted EPS (in
thousands) 9,224 9,224 9,462 9,462
(1) Non-GAAP adjustment related to Gibbs' assumed support contracts that
were not recognized on a GAAP basis in fiscal 2008 or thereafter due
to business combination accounting rules.
(2) Non-GAAP adjustment to exclude non-cash amortization of acquired
intangible assets.
(3) Non-GAAP adjustment to exclude the effect of deferred taxes.
CIMATRON LIMITED
CONSOLIDATED BALANCE SHEETS
(US Dollars in thousands)
March December
31, 31,
2009 2008
ASSETS
CURRENT ASSETS:
Total cash, cash equivalents and short-term
investments $ 6,738 $ 5,727
Trade receivables 7,581 7,108
Other current assets 2,809 2,697
Total current assets 17,128 15,532
Deposits with insurance companies and
severance pay fund 2,482 2,719
Net property and equipment 1,246 1,312
Total other assets 14,051 14,307
Total assets $ 34,907 $ 33,870
LIABILITIES AND SHAREHOLDERS'EQUITY
CURRENT LIABILITIES:
Short-term bank credit $ 1,370 $ 155
Trade payables 1,876 1,865
Accrued expenses and other liabilities 6,907 7,348
Deferred revenues 4,347 2,348
Total current liabilities 14,500 11,716
LONG-TERM LIABILITIES:
Accrued severance pay 3,622 3,933
Long-term loan 276 293
Deferred tax liability 1,638 1,729
Total long-term liabilities 5,536 5,955
Minority interest (9) (4)
Total shareholders' equity 14,880 16,203
Total liabilities and shareholders'equity $ 34,907 $ 33,870
Contact:
Ilan Erez, Chief Financial Officer
Cimatron Ltd.
Tel. +972-3-531-2121
E-mail: ilane@cimatron.com
Yael Nevat
Commitment-IR.com
Tel: +972-9-714-8866, +972-50-762-6215
E-mail: yael@commitment-IR.com
« Previous Page 1 | 2
